• the big story / Lead Story

    When Wind Met Sun

    In 2015, Dilip Shanghvi raised eyebrows when he invested Rs.18 billion in Suzlon

    Krishna Gopalan - July 18, 2020
  • the big story / Lead Story

    Why Ronnie Screwvala could hit paydirt once more

    The serial entrepreneur has backed upGrad which is growing 100% year-on-year

    Debangana Ghosh - July 04, 2020
  • the big story / Lead Story

    Anil Agarwal is taking public investors for a ride, with Vedanta’s delisting

    For the metals and mining tycoon, the latest attempt at taking Vedanta private is a tried-and-trusted method to maximize promoter value

    V Keshavdev - June 22, 2020
  • the big story / Lead Story

    How far did Baba Ramdev stretch to bag Ruchi Soya?

    Even as the acquisition reeks of crony capitalism, Ruchi Soya’s preferential issue to a mystery investor raises its own questions

    V Keshavdev - June 05, 2020
  • the big story / Lead Story

    Why vertical e-commerce players will thrive despite being worst hit by COVID-19

    These ‘masters of one’ will retain their edge through efficient execution and capital efficiency

    Kripa Mahalingam - May 25, 2020
  • the big story / Lead Story

    India Inc says the three words that changes everything. Hint: It is not what you think

    Work from home — It’s not a favour for employees but an imperative for its survival

    Shruti Venkatesh - May 09, 2020
  • the big story / Lead Story

    Kiran Mazumdar Shaw’s multi-billion dollar baby

    Biocon Biologics’ valuation has raised eyebrows. But the parent has strong growth on its side and a track record of solid execution

    Kripa Mahalingam - April 25, 2020